A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors.

被引：1

作者：

Infante, Jeffrey R.

Naing, Aung

Papadopoulos, Kyriakos P.

Autio, Karen A.

Ott, Patrick Alexander

Wong, Deborah Jean Lee

Falchook, Gerald Steven

Patel, Manish R.

Pant, Shubham

Whiteside, Melinda

Bendell, Johanna C.

Bauer, Todd Michael

Janku, Filip

Javle, Milind M.

Hong, David S.

Oft, Martin

机构：

[1] Sarah Cannon Res Inst Tennessee Oncol, Nashville, TN USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] START Ctr Canc Care, San Antonio, TX USA

[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[5] Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Univ Calif Los Angeles, Los Angeles, CA USA

[7] Sarah Cannon Res Inst HealthONE, Denver, CO USA

[8] Sarah Cannon Res Inst Florida Canc Specialists, Sarasota, FL USA

[9] Univ Oklahoma, Hlth Sci Ctr, Sarah Cannon Res Inst, Oklahoma City, OK USA

[10] ARMO BioSci, Redwood City, CA USA

[11] Tennessee Oncol PLLC, Sarah Cannon Res Inst, Nashville, TN USA

[12] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX 77030 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期

关键词：

D O I：

10.1200/jco.2015.33.15_suppl.3017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3017

引用

页数：1

共 50 条

[11] Anti-tumor activity of PEGylated human IL-10 (AM0010) in patients with pancreatic or colorectal cancer
Papadopoulos, Kyriakos P.
Naing, Aung
Infante, Jeffrey R.
Autio, Karen A.
Ott, Patrick Alexander
Wong, Deborah Jean Lee
Falchook, Gerald Steven
Patel, Manish R.
Pant, Shubham
Whiteside, Melinda
Mumm, John B.
Chan, Ivan H.
Bendell, Johanna C.
Rasco, Drew W.
Shih, Kent C.
Javle, Milind M.
Bauer, Todd Michael
Colen, Rivka R.
Van Vlasselaer, Peter
Oft, Martin
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[12] Clinical activity and safety of pegylated human IL-10 (AM0010) in combination with anti-PD1
Naing, Aung
Papadopoulos, Kyriakos P.
Infante, Jeffrey R.
Wong, Deborah Jean Lee
Autio, Karen A.
Ott, Patrick Alexander
Falchook, Gerald Steven
Patel, Manish R.
Pant, Shubham
Patnaik, Amita
Mumm, John B.
Whiteside, Melinda
Chan, Ivan H.
Bendell, Johanna C.
Bauer, Todd Michael
Janku, Filip
Colen, Rivka R.
Tannir, Nizar M.
Van Vlasselaer, Peter
Oft, Martin
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[13] Efficacy and immune activation with PEGylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC: Update
Wong, D. J.
Schneider, J. G.
Aljumaily, R.
Korn, M. W.
Autio, K.
Infante, J. R.
Patel, M. R.
Papadopoulos, K.
Naing, A.
Gabrail, N.
Munster, P.
Goldman, J.
Van Vlasselaer, P.
Hung, A.
Brown, G.
Oft, M.
Garon, E. B.
ANNALS OF ONCOLOGY, 2017, 28
[14] Efficacy, safety, and immune activation with pegylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC.
Wong, Deborah Jean Lee
Schneider, Jeffrey Gary
Aljumaily, Raid
Korn, Wolfgang Michael
Infante, Jeffrey R.
Patel, Manish R.
Autio, Karen A.
Papadopoulos, Kyriakos P.
Naing, Aung
Gabrail, Nashat Y.
Munster, Pamela N.
Goldman, Jonathan Wade
Van Vlasselaer, Peter
Brown, Gail Linda
Hung, Annie
Oft, Martin
Garon, Edward B.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[15] Pegilodecakin, a Pegylated Human IL-10 (AM0010), Enhances the Cytotoxicity of CAR-T Cells in Vitro and In Vivo
McCauley, Scott
Verma, Rakesh
Oft, Martin
BLOOD, 2018, 132
[16] Efficacy, safety, and immune activation with pegylated human IL-10 (AM0010) plus FOLFOX in metastatic pancreatic adenocarcinoma (PDAC).
Hecht, J. Randolph
Falchook, Gerald Steven
Patel, Manish R.
Aljumaily, Raid
Infante, Jeffrey R.
Naing, Aung
Wong, Deborah Jean Lee
Autio, Karen A.
Ratti, Navneet
Wainberg, Zev A.
Bendel, Johanna C.
Pant, Shubham
Brown, Gail Linda
Van Vlasselaer, Peter
Oft, Martin
Papadopoulos, Kyriakos P.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[17] Antitumor activity and immune correlates of PEGylated human IL-10 (AM0010) alone or in combination with anti-PD-1
Naing, Aung
Infante, Jeffrey R.
Papadopoulos, Kyriakos P.
Wong, Deborah J.
Autio, Karen A.
Falchook, Gerald S.
Patel, Manish
Pant, Shubham
Patnaik, Amita
Whiteside, Melinda
Bendell, Johanna C.
Mumm, John
Chan, Ivan H.
Brown, Gail L.
VanVlasselaer, Peter
Hecht, J. R.
Hong, David S.
Tannir, Nizar M.
Oft, Martin
CANCER IMMUNOLOGY RESEARCH, 2016, 4 (11)
[18] Efficacy and safety of pegylated human IL-10 (AM0010) in combination with an anti-PD-1 in renal cell cancer.
Naing, Aung
Infante, Jeffrey R.
Jean, Deborah
Wong, Lee
Korn, Wolfgang Michael
Aljumaily, Raid
Papadopoulos, Kyriakos P.
Autio, Karen A.
Pant, Shubham
Bauer, Todd Michael
Drakaki, Alexandra
Daver, Naval Guastad
Hung, Annie
Van Vlasselaer, Peter
Brown, Gail Linda
Oft, Martin
Tannir, Nizar M.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[19] A first-in-human phase 1 dose escalation study of FF-10850 (liposomal topotecan) in patients with advanced solid tumors.
Matulonis, Ursula A.
Janku, Filip
Moser, Justin C.
Fu, Siqing
Wages, David S.
Wheeler, Catherine A.
Mori, Mikinaga
Shimoyama, Susumu
Yamada, Naoki
Subach, Ruth Ann
Cheung, Kin
Madden, Timothy
Maier, Gary
Johansen, Mary
Falchook, Gerald Steven
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[20] First-in-human dose escalation, safety, and PK study of a novel EFNA4-ADC in patients with advanced solid tumors.
Hong, David S.
Garrido-Laguna, Ignacio
Krop, Ian E.
Subbiah, Vivek
Werner, Theresa Louise
Cotter, Christine M.
Hamilton, Erika Paige
Velastegui, Karen
Xuan, Dawei
Bugarini, Roberto
Gollerkeri, Ashwin
Burris, Howard A.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

← 1 2 3 4 5 →